Results 141 to 150 of about 352,696 (330)
Polymyxins are used against highly resistant Gram‐negative pathogens, and nephrotoxicity (acute kidney injury, AKI) is the major dose‐limiting adverse effect. We aimed to develop a well‐informed population pharmacokinetic/toxicodynamic (PK/TD) model using the largest polymyxin B‐treated critically ill patient population studied to inform polymyxin B ...
Patrick O. Hanafin+19 more
wiley +1 more source
The Composition of Tracheobronchial Secretions in Cystic Fibrosis [PDF]
Warren S. Chernick, Lynne Reid
openalex +1 more source
Inspiration for the Future: The Role of Inspiratory Muscle Training in Cystic Fibrosis. [PDF]
Cystic fibrosis (CF) is an inherited, multi-system, life-limiting disease characterized by a progressive decline in lung function, which accounts for the majority of CF-related morbidity and mortality.
Dekerlegand, Robert L+4 more
core +1 more source
The Joint Heads of Medicines Agencies and European Medicines Agency's (HMA/EMA) big data initiative paves the way for better integration of real‐world data, including data from patient registries, into regulatory decisions on medicines. This article focuses on the outcome of a two‐day multistakeholder workshop organized by EMA in 2024, which explored ...
Kelly Plueschke+24 more
wiley +1 more source
Sex differences in heart failure (HF) management and outcomes in the French‐DataHF cohort. CI, confidence interval; HFH, heart failure hospitalization; HR, hazard ratio; IPW, inverse probability weighting; KM, Kaplan–Meier; LD, loop diuretic; RAS, renin–angiotensin system; RASi, renin–angiotensin system inhibitor.
Guillaume Baudry+7 more
wiley +1 more source
Transient Pulmonary Infiltrations in Cystic Fibrosis due to Allergic Aspergillosis [PDF]
M B Mearns, Warren Young, J C Batten
openalex +1 more source
Contactless Conductivity Detection for Capillary Electrophoresis—Developments From 2020 to 2024
ABSTRACT The review covering the development of capillary electrophoresis with capacitively coupled contactless conductivity detection from 2020 to 2024 is the latest in a series going back to 2004. The article considers applications employing conventional capillaries and planar lab‐on‐chip devices as well as fundamental and technical developments of ...
Peter C. Hauser, Pavel Kubáň
wiley +1 more source